187 related articles for article (PubMed ID: 2576354)
21. Pharmacokinetics of picumast dihydrochloride and its active metabolites M1 and M2 in humans.
Neugebauer G; Wittenbrink-Dix AM; Woelke-Seidl E; Kaufmann B; Ponton T; Dahmen W; Mosberg H; Nieder N; Besenfelder E
Arzneimittelforschung; 1989 Oct; 39(10A):1336-9. PubMed ID: 2576358
[TBL] [Abstract][Full Text] [Related]
22. Effects of inhaled KAA-276, a selective histamine H1 receptor antagonist, on antigen- and histamine-induced bronchoconstriction in animals.
Kobayashi T; Takehana Y; Shinagawa K; Tsuyuki S; Tokutake Y; Sato M; Momose D
Arzneimittelforschung; 1998 Aug; 48(8):826-31. PubMed ID: 9748711
[TBL] [Abstract][Full Text] [Related]
23. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y
Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
[TBL] [Abstract][Full Text] [Related]
24. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
Gonzalez Alvarez R; Kazimierczak W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):333-9. PubMed ID: 6135406
[TBL] [Abstract][Full Text] [Related]
25. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
Casey FB; Abboa-Offei BE; Marretta J
J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610
[TBL] [Abstract][Full Text] [Related]
26. CI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergy.
Adolphson RL; Finkel MP; Robichaud LJ
Int J Immunopharmacol; 1987; 9(1):51-60. PubMed ID: 2438239
[TBL] [Abstract][Full Text] [Related]
27. A placebo-controlled comparison of the efficacy and tolerability of picumast dihydrochloride and terfenadine in patients with seasonal allergic rhinitis.
Boerner D; Metz K; Eberhardt R; Schürmann W
Arzneimittelforschung; 1989 Oct; 39(10A):1356-9. PubMed ID: 2576363
[TBL] [Abstract][Full Text] [Related]
28. Double-blind controlled crossover study comparing the protective effect of picumast dihydrochloride versus placebo following nasal allergen challenge.
Franke W; Bachert C; Messinger D
Arzneimittelforschung; 1989 Oct; 39(10A):1354-6. PubMed ID: 2576362
[TBL] [Abstract][Full Text] [Related]
29. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
[TBL] [Abstract][Full Text] [Related]
30. The pharmacologic profile of wy-41,195, a new orally effective antiallergic agent.
Carlson RP; Dervinis A; DiLuigi JM; Capetola RJ; Rosenthale ME; Lewis AJ
Arzneimittelforschung; 1982; 32(12):1546-53. PubMed ID: 6186261
[TBL] [Abstract][Full Text] [Related]
31. Pharmacologic studies on W10,294A, a new bronchodilator.
Giles RE; Williams JC; Finkel MP
J Pharmacol Exp Ther; 1977 Dec; 203(3):701-11. PubMed ID: 21958
[TBL] [Abstract][Full Text] [Related]
32. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent.
Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
J Pharmacol Exp Ther; 1976 Jun; 197(3):725-33. PubMed ID: 58988
[TBL] [Abstract][Full Text] [Related]
33. Acceptability, safety and efficacy of picumast dihydrochloride on long-term use in patients with perennial bronchial asthma.
Boerner D; Metz K; Eberhardt R
Arzneimittelforschung; 1989 Oct; 39(10A):1372-4. PubMed ID: 2576367
[TBL] [Abstract][Full Text] [Related]
34. Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.
Poizot A; Dumez D; Ferrandon P; Lefournier C; Michel A; Armstrong JM
Arzneimittelforschung; 1986 Apr; 36(4):695-702. PubMed ID: 2424463
[TBL] [Abstract][Full Text] [Related]
35. Antiallergic/antiasthmatic effect of novel antiallergic hexapeptide-95/220 in various experimental models.
Singh R; Nath A; Gupta PP; Shukla M; Khare SK; Kundu B
Indian J Exp Biol; 2001 Sep; 39(9):871-7. PubMed ID: 11831367
[TBL] [Abstract][Full Text] [Related]
36. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells.
Han EH; Park JH; Kim JY; Jeong HG
Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399
[TBL] [Abstract][Full Text] [Related]
37. BL-5255, a tetrazolylpyrimidinone with potent oral antiallergy activity in animals.
Siminoff P; Reed FC; Schurig JE; Juby PF
Monogr Allergy; 1979; 14():318-23. PubMed ID: 91959
[TBL] [Abstract][Full Text] [Related]
38. Antiallergic action of betotastine besilate (TAU-284) in animal models: A comparison with ketotifen.
Ueno M; Inagaki N; Nagai H; Koda A
Pharmacology; 1998 Oct; 57(4):206-14. PubMed ID: 9730778
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of picumast dihydrochloride in patients with liver cirrhosis.
Neugebauer G; Raedsch R; Stiehl A; Kaufmann B; Besenfelder E; Neubert P; Walter-Sack I
Arzneimittelforschung; 1989 Oct; 39(10A):1343-7. PubMed ID: 2576360
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
Evans DP; Thomson DS
Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
